| | IBD | UC | CD | Healthy controls |
|---|
| | (n = 226) | (n = 189) | (n = 37) | (n = 290) |
|---|
CMV detection | n (%) | n (%) | n (%) | n (%) |
DNA DNA+ | 90 (84.07)a | 161 (85.19)d | 29 (78.38)g | 173 (59.66) |
Serum CMV IgG+ | 172 (76.11)b | 139 (73.54)e | 33 (89.19)h | 147 (50.69) |
Serum CMV IgM+ | 4 (1.77)c | 3 (1.59)f | 1 (2.70)i | 1 (0.34) |
- a Compare with healthy controls, OR = 3.569, 95% CI: 2.330-5.468, P < 0.001;
- b Compare with healthy controls, OR = 3.099, 95% CI: 2.113-4.543, P < 0.001;
- c Compare with healthy controls, OR = 5.207, 95% CI: 0.578-46.914, P = 0.235;
- d Compare with healthy controls, OR = 3.889, 95% CI:2.443-6.190, P < 0.001;
- e Compare with healthy controls, OR = 2.704, 95% CI:1.819-4.022, P < 0.001;
- f Compare with healthy controls, OR = 4.661, 95% CI:0.481-45.148, P = 0.344;
- g Compare with healthy controls, OR = 2.452, 95% CI:1.083-5.550, P = 0.027;
- h Compare with healthy controls, OR = 8.026, 95% CI:2.772-23.232, P < 0.001;
- i Compare with healthy controls, OR = 8.028, 95% CI:0.491-131.142, P = 0.540.
- IBD, inflammatory bowel disease; CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease.
